190 related articles for article (PubMed ID: 30464254)
21. Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
Godoy LD; Liberato JL; Celani MVB; Gobbo-Neto L; Lopes NP; Dos Santos WF
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28841161
[TBL] [Abstract][Full Text] [Related]
22. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
Klein S; Bankstahl M; Löscher W
Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186
[TBL] [Abstract][Full Text] [Related]
23. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model.
Paradiso B; Marconi P; Zucchini S; Berto E; Binaschi A; Bozac A; Buzzi A; Mazzuferi M; Magri E; Navarro Mora G; Rodi D; Su T; Volpi I; Zanetti L; Marzola A; Manservigi R; Fabene PF; Simonato M
Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7191-6. PubMed ID: 19366663
[TBL] [Abstract][Full Text] [Related]
24. An on demand macaque model of mesial temporal lobe seizures induced by unilateral intra hippocampal injection of penicillin.
Sherdil A; Chabardès S; Guillemain I; Michallat S; Prabhu S; Pernet-Gallay K; David O; Piallat B
Epilepsy Res; 2018 May; 142():20-28. PubMed ID: 29547770
[TBL] [Abstract][Full Text] [Related]
25. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
[TBL] [Abstract][Full Text] [Related]
26. Epilepsy Gene Therapy Using an Engineered Potassium Channel.
Snowball A; Chabrol E; Wykes RC; Shekh-Ahmad T; Cornford JH; Lieb A; Hughes MP; Massaro G; Rahim AA; Hashemi KS; Kullmann DM; Walker MC; Schorge S
J Neurosci; 2019 Apr; 39(16):3159-3169. PubMed ID: 30755487
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous recurrent seizures and neuropathology in the chronic phase of the pilocarpine and picrotoxin model epilepsy.
Hamani C; Mello LE
Neurol Res; 2002 Mar; 24(2):199-209. PubMed ID: 11877905
[TBL] [Abstract][Full Text] [Related]
28. Viral vector strategy for glial cell line-derived neurotrophic factor therapy for stroke.
Wang Y; Alexander OB; Woodward-Pu YM; Stahl CE; Borlongan CV
Front Biosci; 2006 Jan; 11():1101-7. PubMed ID: 16146800
[TBL] [Abstract][Full Text] [Related]
29. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation.
Humpel C; Hoffer B; Strömberg I; Bektesh S; Collins F; Olson L
Neuroscience; 1994 Apr; 59(4):791-5. PubMed ID: 8058121
[TBL] [Abstract][Full Text] [Related]
30. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review.
Löscher W
Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):531-47. PubMed ID: 6439966
[TBL] [Abstract][Full Text] [Related]
31. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy.
Brandt C; Potschka H; Löscher W; Ebert U
Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980
[TBL] [Abstract][Full Text] [Related]
33. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy.
Hellier JL; Patrylo PR; Buckmaster PS; Dudek FE
Epilepsy Res; 1998 Jun; 31(1):73-84. PubMed ID: 9696302
[TBL] [Abstract][Full Text] [Related]
34. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
35. Asynchronous Distributed Multielectrode Microstimulation Reduces Seizures in the Dorsal Tetanus Toxin Model of Temporal Lobe Epilepsy.
Desai SA; Rolston JD; McCracken CE; Potter SM; Gross RE
Brain Stimul; 2016; 9(1):86-100. PubMed ID: 26607483
[TBL] [Abstract][Full Text] [Related]
36. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury.
Minnich JE; Mann SL; Stock M; Stolzenbach KA; Mortell BM; Soderstrom KE; Bohn MC; Kozlowski DA
Restor Neurol Neurosci; 2010; 28(3):293-309. PubMed ID: 20479525
[TBL] [Abstract][Full Text] [Related]
37. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
Löscher W
Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
[TBL] [Abstract][Full Text] [Related]
38. Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy.
Falcicchia C; Paolone G; Emerich DF; Lovisari F; Bell WJ; Fradet T; Wahlberg LU; Simonato M
Mol Ther Methods Clin Dev; 2018 Jun; 9():211-224. PubMed ID: 29766029
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal cell loss and propagation of abnormal discharges accompanied with the expression of tonic convulsion in the spontaneously epileptic rat.
Hanaya R; Sasa M; Sugata S; Tokudome M; Serikawa T; Kurisu K; Arita K
Brain Res; 2010 Apr; 1328():171-80. PubMed ID: 20211153
[TBL] [Abstract][Full Text] [Related]
40. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
Bethmann K; Brandt C; Löscher W
Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
